Global Cannabis Regulatory Summit Announced by Artemis Growth Partners
Artemis Growth Partners announced the first Global Cannabis Regulatory Summit taking place in March 2025.
Image | adobe.stock/kasto
Artemis Growth Partners announced in a recent press release that the investment group would be partnering with Tenacious Labs to host the first Global Cannabis Regulatory Summit (GCRS). This event will take place at the United States Capitol Complex during March 26-27, 2025. The summit hopes to encourage “global connectivity and partnership amongst regulators, industry, and investors,” (1).
Anticipated for 2025, global cannabis sales within regulated markets are predicted to climb to $51 billion, according to New Frontier Data (2). Attendees at the Global Cannabis Regulatory Summit will include international policy experts, industry executives, and members of Congress (1). In the press release, it mentions that at the event (1) “…ideas will be shared and discussed in an effort to expedite the momentum of cannabis legalization in different jurisdictions and its potential to foster global development.” Attendees will be able to network with international regulators, as well as others within the cannabis industry, and be able to learn from other’s experiences to help grow the industry.
On the night of March 25, 2025, a reception will be held and then on March 26, 2025, the first day of the summit will consist of informative panel discussions on a variety of topics such as, the medical cannabis market. A dinner where attendees will be able to network, will be hosted after the event (1). For day two of the summit, there will be panels covering subjects such as (1), “Cannabis in the Americas, Moving from Prohibition to Regulation in Europe, Emerging and New Sovereign Markets/Rest of World and Unlocking Global Economic Growth.”
“After much research and hard work, we are thrilled to finally be able to provide a crucially needed space for regulators and experts of the highest levels to convene and discuss the outlook of the global cannabis market,” Will Muecke, co-founder and chief investment officer of Artemis Growth Partners, said (1).
Muecke further mentioned in the press release (1), “As legislation evolves and markets come online at different paces all over the world, it is becoming clearer that an interconnected supply chain of both product and capital will prove vital for long-term growth, sustainability and patient benefit. The Global Cannabis Regulatory Summit aims to be the setting for the pivotal connections that will shape the future. We hope that the success of the summit this year will make the GCRS an annual must-attend event for regulators, industry players, and investors in cannabis operators.”
References
- Artemis Growth Partners. Artemis Growth Partners announce inaugural Global Cannabis Regulatory Summit https://www.prnewswire.com/news-releases/artemis-growth-partners-announce-inaugural-global-cannabis-regulatory-summit-302370343.html (accessed Feb 12, 2025).
- New Frontier Data Projects Doubling of global legal cannabis sales to USD $51B by 2025 https://newfrontierdata.com/cannabis-insights/new-frontier-data-projects-doubling-of-global-legal-cannabis-sales-to-usd-51b-by-2025/ (accessed Feb 12, 2025).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Best of the Week: February 7 – February 13, 2025
February 14th 2025Here, we bring you our top five recent news articles covering announcements from the US Hemp Roundtable, the latest cannabis research studies, and additional editorial commentary on the prevalence of schizophrenia after cannabis legalization.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
